Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
139.46B
Market cap139.46B
Price-Earnings ratio
13.04
Price-Earnings ratio13.04
Dividend yield
6.97%
Dividend yield6.97%
Average volume
37.88M
Average volume37.88M
High today
$24.89
High today$24.89
Low today
$24.30
Low today$24.30
Open price
$24.75
Open price$24.75
Volume
41.70M
Volume41.70M
52 Week high
$30.43
52 Week high$30.43
52 Week low
$20.92
52 Week low$20.92

PFE News

Seeking Alpha 2d
Pfizer collaboration with Olema may spark future bidding war - analyst

Olema Pharmaceutical's (NASDAQ:OLMA) announcement of a new clinical trial collaboration and supply agreement with Pfizer Inc. (PFE) in metastatic breast cancer...

Pfizer collaboration with Olema may spark future bidding war - analyst
TipRanks 2d
Oppenheimer says Olema collaboration with Pfizer could lead to bidding war

Oppenheimer analyst Matthew Biegler says the firm had a chance to speak with Olema Oncology (OLMA) management after yesterday’s announcement that Pfizer (PFE) w...

Seeking Alpha 2d
Pfizer responds to Trump’s criticism on COVID success; to share data for new COVID shot

Healthcare Pfizer responds to Trump’s criticism on COVID success; to share data for new COVID shot Sep. 03, 2025 10:51 AM ET Pfizer Inc. (PFE) Stock, BNTX Stock...

Pfizer responds to Trump’s criticism on COVID success; to share data for new COVID shot

Analyst ratings

63%

of 24 ratings
Buy
33.3%
Hold
62.5%
Sell
4.2%

More PFE News

TipRanks 2d
Pfizer reaffirms transparency of COVID vaccine data

Pfizer (PFE) reaffirmed its commitment to transparently and consistently disclosing its research findings regarding its COVID-19 vaccine and to maintaining the...

Seeking Alpha 3d
Pfizer, Moderna in focus as Trump demands answers on COVID success

Pandemic-era favorites such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) will be under scrutiny after President Donald Trump on Monday urged the companies to...

Pfizer, Moderna in focus as Trump demands answers on COVID success
Benzinga 3d
Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions

President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs. Trump Demands Drug Firms Revea...

Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions
Benzinga 4d
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works

Former Centers for Disease Control and Prevention immunizations chief Demetre Daskalakis said Sunday he resigned because politics has overrun science at the nat...

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.